We are live on ! Find out more
Jupiter Topco

Jupiter Topco Portfolio holdings

AUM $245B
This Fund
S&P 500
This Quarter Est. Return
+28.42%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$245B
AUM Growth
–
Cap. Flow
+$233B
Cap. Flow %
94.91%
Top 10 Hldgs %
28%
Holding
2,461
New
2,461
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$16.6B
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.7B
3
AVGO icon
Broadcom
AVGO
+$7.85B
4
MSFT icon
Microsoft
MSFT
+$7.52B
5
AMZN icon
Amazon
AMZN
+$6.22B

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 34.81%
2 Healthcare 20.34%
3 Industrials 12.67%
4 Communication Services 8.25%
5 Consumer Discretionary 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
JA icon
301
Janus Henderson AA-A CLO ETF
JA
$151M
$103M 0.04%
+2,059,750
New +$103M
2026 Q2
0 quarters
RYTM icon
302
Rhythm Pharmaceuticals
RYTM
$7.97B
$103M 0.04%
+925,490
New +$83.7M
2026 Q2
0 quarters
IVV icon
303
iShares Core S&P 500 ETF
IVV
$875B
$102M 0.04%
+136,281
New +$99.2M
2026 Q2
0 quarters
WAL icon
304
Western Alliance Bancorporation
WAL
$8.04B
$102M 0.04%
+1,240,773
New +$98M
2026 Q2
0 quarters
MAZE icon
305
Maze Therapeutics
MAZE
$1.88B
$102M 0.04%
+3,408,045
New +$89.3M
2026 Q2
0 quarters
BRK.B icon
306
Berkshire Hathaway Class B
BRK.B
$1.26T
$102M 0.04%
+203,103
New +$97.6M
2026 Q2
0 quarters
VTR icon
307
Ventas
VTR
$47B
$101M 0.04%
+1,140,949
New +$97.2M
2026 Q2
0 quarters
JABS icon
308
Janus Henderson Asset-Backed Securities ETF
JABS
$138M
$101M 0.04%
+2,023,365
New +$101M
2026 Q2
0 quarters
IMMX icon
309
Immix Biopharma
IMMX
$650M
$101M 0.04%
+9,783,192
New +$90.8M
2026 Q2
0 quarters
NRG icon
310
NRG Energy
NRG
$20.4B
$100M 0.04%
+684,994
New +$98.6M
2026 Q2
0 quarters
ARWR icon
311
Arrowhead Research
ARWR
$6.75B
$100M 0.04%
+1,221,596
New +$90.2M
2026 Q2
0 quarters
EEFT icon
312
Euronet Worldwide
EEFT
$2.61B
$98.2M 0.04%
+1,341,881
New +$93.6M
2026 Q2
0 quarters
TRP icon
313
TC Energy
TRP
$67.5B
$95.9M 0.04%
+1,446,296
New +$95.6M
2026 Q2
0 quarters
KRYS icon
314
Krystal Biotech
KRYS
$9.05B
$95.4M 0.04%
+256,665
New +$76.7M
2026 Q2
0 quarters
BCRX icon
315
BioCryst Pharmaceuticals
BCRX
$1.96B
$95.3M 0.04%
+9,540,764
New +$86.3M
2026 Q2
0 quarters
MLI icon
316
Mueller Industries
MLI
$12B
$95.1M 0.04%
+1,547,480
New +$101M
2026 Q2
0 quarters
CCSI icon
317
Consensus Cloud Solutions
CCSI
$762M
$95M 0.04%
+2,489,846
New +$74.6M
2026 Q2
0 quarters
DRUG icon
318
Bright Minds Biosciences
DRUG
$228M
$94.8M 0.04%
+1,349,107
New +$106M
2026 Q2
0 quarters
LFUS icon
319
Littelfuse
LFUS
$9.8B
$94.6M 0.04%
+207,653
New +$89.9M
2026 Q2
0 quarters
CR icon
320
Crane Co
CR
$12.1B
$94.4M 0.04%
+423,012
New +$79.7M
2026 Q2
0 quarters
CFR icon
321
Cullen/Frost Bankers
CFR
$9.8B
$94.3M 0.04%
+610,241
New +$86.7M
2026 Q2
0 quarters
BLBD icon
322
Blue Bird Corp
BLBD
$1.89B
$94.2M 0.04%
+1,193,431
New +$81M
2026 Q2
0 quarters
XEL icon
323
Xcel Energy
XEL
$52.4B
$94.2M 0.04%
+1,173,563
New +$93.7M
2026 Q2
0 quarters
AMLX icon
324
Amylyx Pharmaceuticals
AMLX
$3.89B
$94M 0.04%
+5,236,102
New +$81M
2026 Q2
0 quarters
BCAX icon
325
Bicara Therapeutics
BCAX
$665M
$94M 0.04%
+3,171,015
New +$70.8M
2026 Q2
0 quarters

Similar funds

Jupiter Topco's Q2 2026 Portfolio in Review

Q2 2026 is the first quarter with a 13F filing on record for Jupiter Topco, which disclosed 2,461 positions worth $245B. Its ten largest holdings account for 28% of the portfolio.

Its largest position is NVIDIA: 80,761,806 shares worth $16.2B.

By sector, the portfolio is most concentrated in Technology at 35% of assets, followed by Healthcare and Industrials.

  • Jupiter Topco's largest Q2 2026 buy was NVIDIA: 80,761,806 shares worth $16.2B.
  • Jupiter Topco's ten largest holdings make up 28% of its $245B portfolio in Q2 2026.
  • Jupiter Topco disclosed 2,461 positions in Q2 2026, its first 13F filing on record.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.